- Phototherapy, a non-invasive treatment method utilizing specific light wavelengths, is increasingly vital in the management of conditions such as neonatal jaundice, psoriasis, vitiligo, and eczema. Its enhanced effectiveness, minimal side effects, and applicability in both hospital and home-care settings have made it a crucial component of modern dermatological and pediatric care
- The escalating demand for phototherapy is primarily fueled by the rising incidence of neonatal hyperbilirubinemia, increasing prevalence of chronic skin disorders, and growing awareness among patients and healthcare providers about the advantages of light-based therapies over systemic medications
- North America dominated the phototherapy market with the largest revenue share of 38.6% in 2024, driven by advanced healthcare infrastructure, favorable reimbursement policies, and the early adoption of LED-based phototherapy systems. The U.S. experienced substantial growth in both hospital and home-use phototherapy device adoption, supported by the presence of key manufacturers and increasing healthcare expenditure
- Asia-Pacific is expected to be the fastest growing region in the phototherapy market during the forecast period, with a CAGR of 8.7% from 2025 to 2032, fueled by rising birth rates, increasing urbanization, improved access to healthcare, and growing awareness of skin conditions. Countries such as India, China, and Japan are emerging as high-growth markets due to their expanding middle-class population and government initiatives to improve neonatal care
- The LED phototherapy equipment segment dominated the held the largest revenue share of 43.2% in 2024, attributed to its high efficacy, low heat emission, and energy efficiency. These devices are preferred in both NICUs and dermatology practices for their performance, safety, and longevity
